Lee Bernstein

The future of nuclear medicine would appear to be the paradigm of personalized medicine — targeted radionuclide therapy to spare healthy tissue, and theranostic medicine, which pairs an imaging isotope with a therapeutic isotope to provide simultaneous, real-time dose delivery and verification, lea…

The decay products of 229Th (t1/2 = 7932 y), specifically 225Ac (t1/2 = 9.92 d) and 213Bi (t1/2 = 45.61 min), are important alpha-emitting radioisotopes for treating cancer…

Targeted alpha therapy has been demonstrated as an effective method for treating cancer. The supply of 225Ac available for clinical applications is limited, so the demand for its precursor, 229Th, is increasing…

Thin, uniform arsenic targets suitable for high-fidelity cross section measurements in stacked-target experiments were prepared by electrodeposition of arsenic on titanium backings from aqueous solutions…